Correlation Between Cheche Group and Elicio Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cheche Group and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cheche Group and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cheche Group Class and Elicio Therapeutics, you can compare the effects of market volatilities on Cheche Group and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cheche Group with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cheche Group and Elicio Therapeutics.

Diversification Opportunities for Cheche Group and Elicio Therapeutics

0.45

Correlation Coefficient

Cheche Group  Elicio Therapeutics

Very weak diversification

The 3 months correlation between Cheche and Elicio is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Cheche Group Class and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Cheche Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cheche Group Class are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Cheche Group i.e., Cheche Group and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Cheche Group and Elicio Therapeutics

Considering the 90-day investment horizon Cheche Group Class is expected to generate 1.12 times more return on investment than Elicio Therapeutics. However, Cheche Group is 1.12 times more volatile than Elicio Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.08 per unit of risk. If you would invest  69.00  in Cheche Group Class on October 9, 2024 and sell it today you would earn a total of  26.00  from holding Cheche Group Class or generate 37.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cheche Group Class  vs.  Elicio Therapeutics

Cheche Group Class

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cheche Group Class are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain fundamental indicators, Cheche Group reported solid returns over the last few months and may actually be approaching a breakup point.

Elicio Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cheche Group and Elicio Therapeutics

The main advantage of trading using opposite Cheche Group and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cheche Group position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.

The idea behind Cheche Group Class and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.